Effect of physician-hospital financial integration on health outcomes and spending ∗

Amy R. Wagner

Abstract:Physician-hospital financial integration rates have surged over the past few years. The Medicare fee rules permit integrated physicians to charge higher prices for office visits. Meanwhile, industry stakeholders claim that integration may promote care coordination and quality, each of which may in turn improve patient health. Economic theory provides mixed evidence about the consequences of physician-hospital financial integration. I examine the effect of physician-hospital financial integration on health outcomes and spending using patient-year level Medicare data, and physicianyear level integration data. I exploit the granularity of this data to make more precise estimates of the effect of integration on health outcomes than previous studies made. I address selection on both patient and physician unobservables by using an instrumental variables model with physician fixed effects. Addressing these two important sources of selection allows me to identify the causal effects of physician-hospital financial integration. I find that having an integrated primary care physician (PCP) does not significantly affect average mortality risk, but does reduce the risk of less severe adverse health outcomes attributable to conditions that are treatable in primary care settings. I also show that attending an integrated PCP does not increase health care spending. Physician-hospital financial integration could potentially impact patient health via several mechanisms. Some of these mechanisms predict that the effect of integration should be heterogeneous over patient characteristics. I test these predictions in the data. My results indicate that inter-specialty coordination is not playing a large role in the beneficial effects of physician-hospital financial integration. I also show that the higher prices associated with integrated PCPs do not reduce access to primary care. I find suggestive evidence that integration increases mortality for low income patients but decreases mortality for high income patients. JEL classification codes: I11, L42

Medicine,Economics